Correlation Between Deutsche Multi and Franklin Biotechnology

Can any of the company-specific risk be diversified away by investing in both Deutsche Multi and Franklin Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Deutsche Multi and Franklin Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Deutsche Multi Asset Moderate and Franklin Biotechnology Discovery, you can compare the effects of market volatilities on Deutsche Multi and Franklin Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Deutsche Multi with a short position of Franklin Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Deutsche Multi and Franklin Biotechnology.

Diversification Opportunities for Deutsche Multi and Franklin Biotechnology

0.27

Correlation Coefficient

Deutsche Multi  Franklin Biotechnology

Modest diversification

The 3 months correlation between Deutsche and Franklin is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Deutsche Multi Asset Moderate and Franklin Biotechnology Discove in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Biotechnology and Deutsche Multi is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Deutsche Multi Asset Moderate are associated (or correlated) with Franklin Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Biotechnology has no effect on the direction of Deutsche Multi i.e., Deutsche Multi and Franklin Biotechnology go up and down completely randomly.

Pair Corralation between Deutsche Multi and Franklin Biotechnology

Assuming the 90 days horizon Deutsche Multi Asset Moderate is expected to generate 0.4 times more return on investment than Franklin Biotechnology. However, Deutsche Multi Asset Moderate is 2.48 times less risky than Franklin Biotechnology. It trades about 0.1 of its potential returns per unit of risk. Franklin Biotechnology Discovery is currently generating about 0.03 per unit of risk. If you would invest  888.00  in Deutsche Multi Asset Moderate on September 28, 2024 and sell it today you would earn a total of  129.00  from holding Deutsche Multi Asset Moderate or generate 14.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Deutsche Multi Asset Moderate  vs.  Franklin Biotechnology Discove

Deutsche Multi Asset

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Deutsche Multi Asset Moderate has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Deutsche Multi is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Franklin Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Franklin Biotechnology Discovery has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Pair Trading with Deutsche Multi and Franklin Biotechnology

The main advantage of trading using opposite Deutsche Multi and Franklin Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Deutsche Multi position performs unexpectedly, Franklin Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Biotechnology will offset losses from the drop in Franklin Biotechnology's long position.

The idea behind Deutsche Multi Asset Moderate and Franklin Biotechnology Discovery pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.